Dr. Daniel V.T. Catenacci's career as an adult gastrointestinal Medical Oncologist started after extensive education, including a Bachelor's degree with honours in Science at the University of Waterloo, in Waterloo, Canada; a Doctorate of Medicine at the Wayne State University School of Medicine in Detroit, Michigan; Residency in Internal Medicine at the University of California, Los Angeles (UCLA), in Westwood, California; then Medical Oncology Fellowship training at the University of Chicago, in Chicago, Illinois. He ultimately became a specialist in Medical Oncology with a focus on Gastrointestinal cancers. Throughout his education, he participated in several unique programs where he developed a broad background in laboratory and clinical translational research, including at the Harvard Institute of Medicine and the University of Chicago, where he obtained a Master of Science in Biostatistics and Clinical Investigation. His primary clinical and research focus has been on gastroesophageal and other gastrointestinal cancers, including pancreatic, hepatobiliary (liver and bile duct), colorectal, and neuroendocrine cancers, where he has been able to conduct both basic and clinical research in the field.
Daniel V.T. Catenacci has previously served as the Director of the Gastrointestinal Oncology program at the University of Chicago, where he provided clinical care for cancer patients, conducted basic and clinical research, and trained clinical and laboratory personnel, including fellows and residents, as well as medical, undergraduate and postgraduate students. He contributed unique discoveries in cancer research, including developing tools to assess and quantify molecular (genomic and proteomic) heterogeneity, both between individuals as well as within a given individual's tumour, which has led to innovative new approaches enabling the implementation of novel therapies based on these biological aspects of tumours.
Daniel V.T. Catenacci © 2022. All rights reserved.